| Price | 355.35 on 17-03-2026 at 08:44:06 |
|---|---|
| Change | -3.20 -0.89% |
| Buy | 363.00 |
| Sell | 347.70 |
| Last Trade: | Unknown 127.00 at 355.35 |
| Day's Volume: | 1,229 |
| Last Close: | 358.55 |
| Open: | 355.35 |
| ISIN: | DK0060336014 |
| Day's Range | 347.70 - 355.35 |
| 52wk Range: | 340.70 - 487.25 |
| Market Capitalisation: | - |
| VWAP: | 355.06497 |
| Shares in Issue: | 465.91m |
Novonesis B Ord (0Q4U) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 127 | 355.35 | SI Trade |
08:44:06 - 17-Mar-26 |
| Unknown* | 127 | 355.35 | OTC Trade |
08:44:06 - 17-Mar-26 |
| Buy* | 33 | 355.40 | SI Trade |
08:41:06 - 17-Mar-26 |
| Buy* | 48 | 355.80 | SI Trade |
08:38:39 - 17-Mar-26 |
| Buy* | 75 | 355.75 | SI Trade |
08:30:00 - 17-Mar-26 |
| Unknown* | 75 | 355.75 | OTC Trade |
08:30:00 - 17-Mar-26 |
| Sell* | 123 | 355.20 | SI Trade |
08:27:29 - 17-Mar-26 |
| Sell* | 133 | 355.10 | SI Trade |
08:20:48 - 17-Mar-26 |
| Sell* | 133 | 355.10 | SI Trade |
08:20:48 - 17-Mar-26 |
| Sell* | 53 | 353.60 | SI Trade |
08:06:33 - 17-Mar-26 |
Novonesis B Ord (0Q4U) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Mar 2026 12:14 pm | RNS-R | Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility |
| 9th Jul 2018 1:13 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 2nd Jul 2018 12:28 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 25th Jun 2018 11:14 am | GNW | Transactions under Novozymes’ stock buyback program |
| 18th Jun 2018 10:06 am | GNW | Transactions under Novozymes’ stock buyback program |
| 11th Jun 2018 11:59 am | GNW | Transactions under Novozymes’ stock buyback program |
| 4th Jun 2018 7:49 am | GNW | Transactions under Novozymes’ stock buyback program |
| 28th May 2018 9:34 am | GNW | Transactions under Novozymes’ stock buyback program |
| 22nd May 2018 12:20 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 14th May 2018 12:21 pm | GNW | Transactions under Novozymes’ stock buyback program |
